Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Michaelis

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
JAAD Case Reports|April 4, 2022
Progressive nodular histiocytosis with dramatic response to cobimetinibPhilip C Berce, Leah Cardwell, Amber N Essenmacher, et al.
Leukemia Research Reports|June 2, 2022
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndromeKristen Corrao, Siam Rezwan, Ehab Atallah, et al.
Haematologica|February 22, 2024
An extensive database analysis demonstrates significant increase in platelet quantity in unselected hospitalized patients following treatment with oseltamivirChandrasekar Muthiah, Qinghua Lian, Samantha Benz, et al.
Leukemia Research|July 9, 2023
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapySkyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, et al.
Leukemia Research|November 19, 2022
Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemiaSameem M Abedin, Talha Badar, Katelyn Gauger, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2020
From Theory to Practice: Implementation of Strategies to Reduce Acute Care Visits in Patients With CancerBobby Daly, Laura C Michaelis, John D Sprandio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2014
Costs of care for lung and colon cancer patients receiving chemotherapy following FDA policy changesKevin T Stroupe, Elizabeth Tarlov, Thomas W Weichle, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 22, 2011
Trends in anemia management in lung and colon cancer patients in the US Department of Veterans Affairs, 2002-2008Elizabeth Tarlov, Kevin T Stroupe, Todd A Lee, et al.
American Journal of Hematology|June 21, 2017
Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysisAdam Levin, Ariel Kleman, Lisa Rein, et al.
Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
JAAD Case Reports|April 4, 2022
Progressive nodular histiocytosis with dramatic response to cobimetinibPhilip C Berce, Leah Cardwell, Amber N Essenmacher, et al.
Leukemia Research Reports|June 2, 2022
Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndromeKristen Corrao, Siam Rezwan, Ehab Atallah, et al.
Haematologica|February 22, 2024
An extensive database analysis demonstrates significant increase in platelet quantity in unselected hospitalized patients following treatment with oseltamivirChandrasekar Muthiah, Qinghua Lian, Samantha Benz, et al.
Leukemia Research|July 9, 2023
Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapySkyler Taylor, Guru Subramanian Guru Murthy, Lyndsey Runaas, et al.
Leukemia Research|November 19, 2022
Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemiaSameem M Abedin, Talha Badar, Katelyn Gauger, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2020
From Theory to Practice: Implementation of Strategies to Reduce Acute Care Visits in Patients With CancerBobby Daly, Laura C Michaelis, John D Sprandio, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2014
Costs of care for lung and colon cancer patients receiving chemotherapy following FDA policy changesKevin T Stroupe, Elizabeth Tarlov, Thomas W Weichle, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 22, 2011
Trends in anemia management in lung and colon cancer patients in the US Department of Veterans Affairs, 2002-2008Elizabeth Tarlov, Kevin T Stroupe, Todd A Lee, et al.
American Journal of Hematology|June 21, 2017
Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysisAdam Levin, Ariel Kleman, Lisa Rein, et al.
Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Pageof 6